LSB 2014-19. Reminder to OASAS certified providers and County LGUs on Federal National Provider Identifier (NPI) requirement. Issued 11/3/14. Supersedes LSB 2006-9.
FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressants: careful medication management can reduce risks.
New York State Department of Health and Office of Alcoholism and Substance Abuse Services best practices for implementing transmucosal buprenorphine for the treatment of opioid use...